Clinical Research on the Effect of Aspirin on the Disease Free Survival Rate of Esophageal Carcinoma

NCT03900871 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Aspirin as an Adjuvant Therapy, to Observe Its Effect on the Disease Free Survival Rate of Patients With Esophageal Squamous Cell Carcinoma

Interventions

DRUG: Acetylsalicylic acid

Sponsor

Hebei Medical University Fourth Hospital